Meeting Coverage
EASL
European Association for the Study of the Liver
Latest EASL Meeting Coverage
"Is it time to say primary prophylaxis is dead?" one expert asks
Urgent need for organ allocation system reform, researchers say
GLP-1/GIP agonist also improved fibrosis biomarkers, liver fat, and stiffness in phase II trial
Effects may be related to weight loss, not changes in fibrogenesis, expert suggests
iLFT is now an essential, highly utilized tool at one U.K. primary care system
Combo therapies for HDV with drugs other than pegylated interferon would be better, expert says
Persistent viral suppression in most patients, even after 8 years
Early model suggests a way to predict progression-free survival
Pilot trial demonstrates that FMT can boost gut health, prevent serious infections
Phase IIb ENLIVEN trial saw success with various doses of pegozafermin
Public health expert describes pivot to provide medical aid in war-torn Ukraine
At 48 weeks, bulevirtide led to undetectable HDV RNA, normalization of ALT in up to 48%
Investigational drug more likely to resolve severe form of fatty liver disease, improve fibrosis
Noteworthy research from the European Association for the Study of the Liver annual meeting
Latest Gastroenterology Meeting Coverage
-
ACG: American College of Gastroenterology
October 2024
-
EASL: European Association for the Study of the Liver
June 2024
-
DDW: Digestive Disease Week
May 2024
-
CCC: Crohn's & Colitis Congress
January 2024